Related Experiment Video
Updated: May 13, 2026
09:13
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
[Maternal diabetes and fetal hypoxia]
Kari Teramo1, Miira Klemetti, Minna Tikkanen
1HYKS Naistenklinikka.
Duodecim; Laaketieteellinen Aikakauskirja
|March 6, 2013
Summary
Perinatal mortality remains high in type 1 diabetes pregnancies due to chronic intrauterine hypoxia. Early detection via amniotic fluid erythropoietin and improved pre-pregnancy care are crucial for better outcomes.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Perinatology
Context:
- Perinatal mortality rates in type 1 diabetic pregnancies have stagnated over the past 30 years.
- Diabetic pregnancies experience significantly higher fetal (5x) and neonatal (3x) death rates compared to the general population.
- Chronic intrauterine hypoxia, stemming from maternal diabetes, is strongly implicated as the primary cause of late-term stillbirths.
Purpose:
- To highlight the persistent issue of elevated perinatal mortality in type 1 diabetic pregnancies.
- To identify fetal hyperglycemia and hyperinsulinemia as contributors to chronic fetal hypoxia.
- To emphasize the diagnostic potential of amniotic fluid erythropoietin for antenatal detection of fetal hypoxia.
Summary:
- Maternal type 1 diabetes leads to chronic intrauterine hypoxia, increasing fetal and neonatal deaths.
- Fetal hyperglycemia and hyperinsulinemia exacerbate hypoxia by elevating fetal oxygen consumption.
- Measuring amniotic fluid erythropoietin offers an antenatal method to detect fetal chronic hypoxia.
Impact:
- Increased pre-pregnancy counseling and enhanced glycemic control are recommended for diabetic women.
- Improved pregnancy surveillance and revised therapeutic strategies are necessary to reduce perinatal mortality.
- This research underscores the need for targeted interventions to improve perinatal outcomes in diabetic pregnancies.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...